0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
Don’t have an account? Signup
The US Food and Drug Administration (FDA) on Tuesday, April 2, 2024, approved Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system for use in leaky tricuspid heart valves.
Share this article
If you liked this article share it with your friends.they will thank you later
/medriva/media/media_files/L8jlRRiw47pZ3nqmpTyz.png)
3 Min read
/medriva/media/agency_attachments/PAJ1yimoQnd9vBc8FTrz.png)
/medriva/media/media_files/JW1Y2Cm26JYNPS4FZ4Gq.png)